Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antipsychotics. A pediatric perspective

R L Findling1, S C Schulz, M D Reed

  • 1Division of Child and Adolescent Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Pediatric Clinics of North America
|January 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2018
Same author

Reward-related neural activity and structure predict future substance use in dysregulated youth.

Psychological medicine·2016
Same author

Correspondence.

Clinical drug investigation·2016
Same author

Reduced Sensitivity to Charge Noise in Semiconductor Spin Qubits via Symmetric Operation.

Physical review letters·2016
Same author

The rationale, design, and progress of two novel maintenance treatment studies in pediatric bipolarity.

Acta neuropsychiatrica·2016
Same author

Predicting clinical outcome from reward circuitry function and white matter structure in behaviorally and emotionally dysregulated youth.

Molecular psychiatry·2016
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Atypical antipsychotics offer improved tolerability for pediatric psychiatric syndromes, but prescribers should exercise caution due to potential serious side effects and limited pediatric data.

Area of Science:

  • Pediatric psychopharmacology
  • Neuroscience
  • Clinical psychiatry

Background:

  • Antipsychotics are widely prescribed for various psychiatric conditions beyond psychosis.
  • Typical antipsychotics have shown some efficacy in pediatric patients but raise safety and tolerability concerns.
  • A new class of atypical antipsychotics offers potential improvements in tolerability and symptom reduction.

Purpose of the Study:

  • To review the current understanding of atypical antipsychotic use in pediatric patients.
  • To highlight the potential benefits and risks associated with these newer agents in young populations.
  • To emphasize the need for further research to guide judicious use in pediatric psychopharmacology.

Main Methods:

  • Review of existing literature on typical and atypical antipsychotic use in pediatric populations.

Related Experiment Videos

  • Discussion of the pharmacological profiles and clinical trial data for atypical antipsychotics.
  • Analysis of safety and tolerability data, including potential adverse events.

    • Main Results:

    • Atypical antipsychotics demonstrate promising preliminary results in pediatric patients, with improved side-effect profiles compared to typical agents.
    • Despite potential benefits, serious adverse events like tardive dyskinesia and neuroleptic malignant syndrome remain a concern.
    • Limited data exists for many atypical antipsychotics specifically in pediatric populations, necessitating cautious interpretation.

    Conclusions:

    • Atypical antipsychotics represent a potentially valuable addition to pediatric psychopharmacology, but their use requires careful consideration of the available evidence.
    • The distinct receptor binding profiles of atypical agents mean that findings for one drug cannot be generalized to others.
    • Further rigorous research is essential to establish optimal dosing, efficacy, and safety for atypical antipsychotics in children and adolescents.